Table of Contents Author Guidelines Submit a Manuscript
Case Reports in Obstetrics and Gynecology
Volume 2014, Article ID 324509, 4 pages
http://dx.doi.org/10.1155/2014/324509
Case Report

Paraneoplastic Internal Jugular Vein Thrombosis Leading to Diagnosis of Bilateral Ovarian Ependymoma

Department of Medical and Pediatric Oncology, GCRI, Civil Hospital Campus, Ahmedabad, Gujarat 830016, India

Received 2 April 2014; Accepted 12 May 2014; Published 21 May 2014

Academic Editor: Kaei Nasu

Copyright © 2014 Irappa Madabhavi et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. C. C. Boedeker, G. J. Ridder, N. Weerda, W. Maier, T. Klenzner, and J. Schipper, “Etiology and therapy of the internal jugular vein thrombosis,” Laryngo-Rhino-Otologie, vol. 83, no. 11, pp. 743–749, 2004. View at Publisher · View at Google Scholar · View at Scopus
  2. A. S. Adamson, T. J. Littlewood, G. J. Poston, J. M. Hows, and J. N. Wolfe, “Malignancy presenting as peripheral venous gangrene,” Journal of the Royal Society of Medicine, vol. 81, no. 10, pp. 609–610, 1988. View at Google Scholar · View at Scopus
  3. V. Garcia-Barriola, M. N. de Gomez, J. A. Suarez, C. Lara, J. E. Gonzalez, and J. Garcia-Tamayo, “Ovarian ependymoma. A case report,” Pathology—Research and Practice, vol. 196, no. 8, pp. 595–599, 2000. View at Google Scholar · View at Scopus
  4. F. R. Rickles, “Mechanisms of cancer-induced thrombosis in cancer,” Pathophysiology of Haemostasis and Thrombosis, vol. 35, no. 1-2, pp. 103–110, 2006. View at Google Scholar · View at Scopus
  5. G. J. Caine, P. S. Stonelake, G. Y. H. Lip, and S. T. Kehoe, “The hypercoagulable state of malignancy: pathogenesis and current debate,” Neoplasia, vol. 4, no. 6, pp. 465–473, 2002. View at Publisher · View at Google Scholar · View at Scopus
  6. J. A. Heit, M. D. Silverstein, D. N. Mohr, T. M. Petterson, W. M. O'Fallon, and L. J. Melton III, “Risk factors for deep vein thrombosis and pulmonary embolism: a population-based case-control study,” Archives of Internal Medicine, vol. 160, no. 6, pp. 809–815, 2000. View at Google Scholar · View at Scopus
  7. G. F. von Tempelhoff, M. Dietrich, F. Niemannal, D. Schneider, G. Hommel, and L. Heilmann, “Blood coagulation and thrombosis in patients with ovarian malignancy,” Journal of Thrombosis and Haemostasis, vol. 77, pp. 456–461, 1997. View at Google Scholar
  8. S. Molnar, H. Guglielmone, M. Lavarda, M. L. Rizzi, and G. Jarchum, “Procoagulant factors in patients with cancer,” Hematology, vol. 12, no. 6, pp. 555–559, 2007. View at Publisher · View at Google Scholar · View at Scopus
  9. M. E. Velasco, D. Dahl, U. Roessmann, and P. Gambetti, “Immunohistochemical localization of glial fibrillary acidic protein in human glial neoplasms,” Cancer, vol. 45, no. 3, pp. 484–494, 1980. View at Google Scholar · View at Scopus
  10. T. Takano, J. Akahira, T. Moriya et al., “Primary ependymoma of the ovary: a case report and literature review,” International Journal of Gynecological Cancer, vol. 15, no. 6, pp. 1138–1141, 2005. View at Publisher · View at Google Scholar · View at Scopus
  11. B. Deval, P. Rousset, C. Bigenwald, F. F. Nogales, and J. Alexandre, “Treatment of ovarian anaplastic ependymoma by an aromatase inhibitor,” Obstetrics & Gynecology, vol. 123, Supplement 2, no. 2, part 2, pp. 488–491, 2014. View at Publisher · View at Google Scholar